Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03174379 · ClinicalTrials.gov registry record · NA

A Study to Analyze the Effect of Acupuncture on Mobility And Quality of Life in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT03174379 is a NA study of Multiple Sclerosis that has completed, run by NYU Langone Health. The registered enrollment target is 13 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03174379, a NA study of Multiple Sclerosis, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The purpose of this two-center study is to examine the effectiveness of acupuncture treatments in addressing mobility deficits, sensorimotor impairment, and quality of life (QOL) limitations in persons with Multiple Sclerosis (MS). It is hypothesized that acupuncture will result in an improvement in these limitations.

Conditions Studied

Interventions

  • PROCEDURE Acupuncture
  • PROCEDURE Standard of Care with no acupuncture

Study Locations (1)

New York

  • New York University School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2017-06-05
Est. Completion 2019-06-06
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03174379

The ClinicalTrials.gov registry entry for NCT03174379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Acupuncture is the first listed.

NCT03174379 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03174379 about?

NCT03174379 is a clinical study titled "A Study to Analyze the Effect of Acupuncture on Mobility And Quality of Life in Multiple Sclerosis". The purpose of this two-center study is to examine the effectiveness of acupuncture treatments in addressing mobility deficits, sensorimotor impairment, and quality of life (QOL) limitations in persons with Multiple Sclerosis (MS). It is hypothesized that acupuncture will result in an improvement in...

What is the current status of trial NCT03174379?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-06-05. Estimated completion is 2019-06-06.

What conditions does trial NCT03174379 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT03174379?

The interventions under investigation include: Acupuncture (PROCEDURE), Standard of Care with no acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT03174379?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03174379 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.